Mark Mallon

Insider Reports History

Location
Boston, MA
Signature
/s/ Halley E. Gilbert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Mallon:

Company Role Class Num Shares Value Price $ Report Date Ownership
NEOGENOMICS INC Chief Executive Officer, Director Stock Option (Right to Buy) 347,777 $15,284,799 $43.95 01 Mar 2022 Direct
NEOGENOMICS INC Chief Executive Officer, Director Common Stock 368,051 $6,768,458 $18.39 01 Mar 2022 Direct

Insider Reports Filed by Mark Mallon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NEO NEOGENOMICS INC 01 Mar 2022 2 $0 4 Chief Executive Officer, Director 03 Mar 2022, 18:59
NEO NEOGENOMICS INC 30 Dec 2021 1 $0 4 Chief Executive Officer, Director 30 Dec 2021, 17:05
NEO NEOGENOMICS INC 06 Dec 2021 1 +$520,710 4 Chief Executive Officer, Director 06 Dec 2021, 15:16